Hantavirus on Cruise Ships: A Survivor's Story and a Stark Warning
WHO assesses public health risk as low, but a rare and deadly virus has prompted urgent questions about access to critical care.
A cluster of hantavirus cases linked to a cruise ship has raised public concern, even as the World Health Organization (WHO) assesses the public health risk as low. Hantavirus pulmonary syndrome (HPS) is a rare rodent-borne disease with an estimated mortality rate of 35% to 47%. There is no specific antiviral treatment; care focuses on symptom management.
A 14-Year-Old’s Race Against Time
In July 2022, a 14-year-old patient named Evie was admitted to Cincinnati Children's Hospital with rapidly progressive respiratory failure. Within 12 hours, she required mechanical ventilation. Within 24 hours, she developed shock and was placed on extracorporeal membrane oxygenation (ECMO), a heart-lung bypass machine.
Without ECMO, the patient would not have survived.
Diagnosis of hantavirus took approximately one week. The patient had pulmonary edema, a possible symptom. The diagnosis was considered only after recognizing the rapid progression and the patient's travel history from North Dakota, where hantavirus is present.
The Harrowing Treatment Path
No direct antiviral treatment exists. ECMO provided life support for five days. The patient experienced cardiac arrest during ECMO cannulation and received chest compressions for nine minutes before heart function resumed. After ECMO, she remained on a ventilator for several days before the breathing tube was removed.
Total hospital stay was about one month: over two weeks in the ICU, and 11 days on a general ward.
A Critical Limitation: ECMC Access
The attending physician, Andrew Lautz, MD, a pediatric ICU doctor, stated that hantavirus can rapidly progress in healthy individuals and requires a coordinated medical team.
ECMO is not available at all hospitals due to required surgical expertise and risks (e.g., stroke, bleeding, organ dysfunction).
Dr. Lautz expressed concern for cruise ship patients regarding their access to critical care. He noted that the high mortality reflects diagnostic difficulty and the challenge of quickly accessing critical care.
Key Facts to Remember
- Mortality rate: 35%-47% per WHO.
- No specific cure or antiviral treatment exists.
- Diagnosis is difficult; testing may not be rapidly available.
- The virus is not endemic to Ohio; the patient contracted it in North Dakota.
- ECMO was critical for survival in this case.
- The WHO states the public health risk from the cruise cluster is low.